Next Article in Journal
End-of-Induction Response and Tolerability of High-Risk Neuroblastoma Treated with Chemoimmunotherapy—Modified N7 Regimen with Dinutuximab Beta
Previous Article in Journal
Efficacy and Safety of Dalpiciclib in HR-Positive Advanced Breast Cancer: A Two-Center Retrospective Study
 
 
Article

Article Versions Notes

Cancers 2026, 18(6), 1026; https://doi.org/10.3390/cancers18061026
Action Date Notes Link
article html file updated 22 March 2026 10:04 CET Original file https://www.mdpi.com/2072-6694/18/6/1026/html
article supplementary file uploaded. 22 March 2026 10:02 CET - https://www.mdpi.com/2072-6694/18/6/1026#supplementary
article pdf uploaded. 22 March 2026 10:02 CET Version of Record https://www.mdpi.com/2072-6694/18/6/1026/pdf
article xml uploaded. 22 March 2026 10:02 CET Update https://www.mdpi.com/2072-6694/18/6/1026/xml
article xml file uploaded 22 March 2026 10:02 CET Original file -
Back to TopTop